Karanja Taila (Pongamia pinnata Seed Oil): Uses, Evidence & Safety

TL;DR

Karanja Taila is the oil pressed from the seeds of Karanja (Pongamia pinnata), traditionally applied to skin conditions, itching, and wounds. No human trial of the oil was identified in the reviews surveyed; laboratory and animal studies show antimicrobial, anti-inflammatory, and wound-related activity. Evidence supports interest, not efficacy: and it is a traditional external-use preparation, not a cooking oil.

What it is

Karanja Taila is the oil obtained from the seeds of Pongamia pinnata (Linn.) Pierre: synonym Millettia pinnata (L.): a medium-sized evergreen tree of the legume family (Fabaceae/Leguminosae), known as Karanja (Hindi, Marathi, Bengali), Maktamala or Gaura (Sanskrit), and the Indian beech tree or Pongam oil tree (English) (Preethima et al., Int J Pharm Sci Rev Res 2019). The seeds are reported as containing 28–34% oil: predominantly oleic acid (44.24%), stearic acid (29.64%), and palmitic acid (18.58%): along with sterols and signature furanoflavonoids: karanjin, pongamol, pongagalabrone, pongapin, pinnatin, kanjone, glabrin, and karanjachromene. Karanja Taila is a traditional external-use medicinal oil, not a cooking oil: a distinction the whole article maintains.

Traditional use

In Ayurveda and Siddha, Pongamia pinnata is described as one of the oldest plants used for healing (Preethima et al., IJPSRR 2019). Traditional applications of the tree include wounds, ulcers, painful rheumatic joints, piles, skin diseases, and itching. The seed oil was specifically used for scabies, while seed powder was used for febrile conditions, whooping cough, bronchitis, ulcers, leprosy, piles, and chronic fever. Leaves were applied for wound healing and rheumatic pain; bark as an antimicrobial and for bleeding piles; and extracts of leaves, seeds, and roots for leukoderma, leprosy, lumbago, and muscular or articular rheumatism. These are traditional claims, not clinical proof: the human evidence is assessed separately below.

What modern research says

No human trial identified

This is the decisive fact. A 2026 peer-reviewed review of Pongamia pinnata states that although preclinical studies have shown a favourable safety profile, "inadequate clinical validation and the need for standardised formulations remain two major barriers to therapeutic translation" (Dudhatra et al., Antiinflamm Antiallergy Agents Med Chem 2026). No published human trial of Karanja Taila was identified in the reviews surveyed.

Oil-specific laboratory evidence

The one study on the oil itself comes from the laboratory: the fatty oil of Pongamia pinnata showed antifungal and antibacterial activity against Aspergillus niger, A. fumigatus, Staphylococcus aureus, and Pseudomonas aeruginosa (Wagh et al. 2007, via Preethima et al., IJPSRR 2019). Petri-dish antimicrobial activity is not evidence that the oil treats skin infections in people.

Animal evidence (whole plant and seed extracts)

The remaining evidence base, all preclinical, is summarized in the same peer-reviewed review (Preethima et al., IJPSRR 2019):

What has not been tested in humans

Everything the oil is traditionally used for, eczema, psoriasis, scabies, wounds, ulcers, fungal infections, has no published human trial. The bulk of Karanja Taila's reputation rests on traditional use plus laboratory and animal work.

Safety & contraindications

The 2019 review characterizes Pongamia pinnata as traditionally used with a "nontoxic nature with no/minimal side effects," while the 2026 review stresses that clinical validation is inadequate and preclinical safety findings are the only data available (Preethima et al., IJPSRR 2019; Dudhatra et al. 2026). Practical cautions: the oil is traditionally for external use only, do not swallow it (karanjin, a seed furanoflavonoid, is developed as a biopesticide, and the seeds have been used traditionally as fish poison). Patch-test on a small skin area first, as concentrated herbal oils can irritate; do not apply to seriously infected, rapidly spreading, or non-healing wounds without medical assessment; and avoid in pregnancy and breastfeeding, no human safety data exist. No clinical-trial or pharmacopoeial dose for the oil was found in the sources consulted, so no dosage is given here; medicinal use should be guided by a qualified practitioner.

FAQs

What is Karanja Taila?

Karanja Taila is the oil pressed from the seeds of Karanja, Pongamia pinnata (Linn.) Pierre (syn. Millettia pinnata), a medium-sized evergreen tree of the legume family. The seeds contain 28–34% oil rich in oleic and stearic acids, plus signature furanoflavonoids karanjin and pongamol (Preethima et al., IJPSRR 2019). It is a traditional external-use oil, not a cooking oil.

What is Karanja Taila traditionally used for?

In Ayurveda and Siddha, Pongamia pinnata is one of the oldest plants used for healing. The seed oil was traditionally applied for scabies, itching, skin diseases, and wounds, while leaves, bark, and roots were used for ulcers, bleeding piles, rheumatic joints, and skin conditions including leucoderma and leprosy (Preethima et al., IJPSRR 2019). These are traditional claims, not clinical proof.

Does Karanja Taila heal wounds or skin infections?

Not proven in humans. The oil itself showed antifungal and antibacterial activity in laboratory tests against Aspergillus niger, A. fumigatus, Staphylococcus aureus, and Pseudomonas aeruginosa (Wagh et al., via Preethima et al., IJPSRR 2019). Seed and leaf extracts reduced inflammation and healed experimental ulcers in rats. Lab and animal findings are not human efficacy: no trial has tested the oil on real wounds or skin infections.

Can I swallow Karanja Taila?

There is no evidence supporting internal use: the oil is traditionally an external-use preparation for skin, human trials are absent, karanjin, a seed furanoflavonoid, is studied and sold as a biopesticide (Preethima et al., IJPSRR 2019), and the seeds have been used traditionally as fish poison. Do not swallow the oil; keep it for external use as directed by a qualified practitioner.

Is Karanja Taila safe in pregnancy?

No human safety data exist for the oil in pregnancy or breastfeeding, so it should be avoided. The review characterizes Pongamia as traditionally nontoxic with minimal side effects, but also stresses that clinical validation is inadequate (Dudhatra et al. 2026). Without pregnancy data, avoiding use while pregnant, breastfeeding, or trying to conceive is the cautious position.

Have there been human trials of Karanja Taila?

None were identified in the reviews surveyed. A 2026 peer-reviewed review of Pongamia pinnata states that inadequate clinical validation and non-standardized formulations remain the two major barriers to therapeutic translation, despite favourable preclinical safety signals (Dudhatra et al. 2026). Every published benefit cited for the oil comes from laboratory or animal studies.

Sources

Disclaimer

This article is for educational purposes only and is not medical advice. Herbal products can interact with medications and are not suitable for everyone. Talk to a qualified healthcare practitioner before use — especially if you are pregnant, breastfeeding, managing a medical condition, or taking prescription medicines.